We describe a powerful new information resource appropriate safeguards for patient anonymity and for scientific and ethical standards of the proposed for pharmacovigilance, pharmaco-economic studies, clinical epidemiology and health service research, studies. This database has depended upon the parti- cipating general practitioners and has already which involves automated linkage of demographic, diagnostic and prescription information on some resulted in a substantial output of studies in peer-